January 11, 2010 – FDA Approves Actemra for the Treatment of Moderately to Severely Active Rheumatoid Arthritis.
Jan 2010 – FDA Approves Actemra
Announcement Date: January 11, 2010
January 11, 2010 – FDA Approves Actemra for the Treatment of Moderately to Severely Active Rheumatoid Arthritis.